These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Homozygous familial hypercholesterolaemia: update on management. France M Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828 [TBL] [Abstract][Full Text] [Related]
3. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia. Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356 [TBL] [Abstract][Full Text] [Related]
4. New Horizons in the Pathogenesis, Pathophysiology and Treatment of Familial Hypercholesterolaemia. Viigimaa M; Heinsar S; Lovic D; Katsimardou A; Piperidou A; Duishvili D Curr Pharm Des; 2018; 24(31):3599-3604. PubMed ID: 30306860 [TBL] [Abstract][Full Text] [Related]
5. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment. Farnier M; Civeira F; Descamps O; Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482 [TBL] [Abstract][Full Text] [Related]
6. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
7. [PCSK9 - "missing link" in familial hypercholesterolemia : New therapeutic options in hypercholesterolemia and coronary artery disease]. Thiery J; Burkhardt R Herz; 2016 Jun; 41(4):281-9. PubMed ID: 27215417 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028 [TBL] [Abstract][Full Text] [Related]
10. Prevention of cardiovascular disease in patients with familial hypercholesterolaemia: The role of PCSK9 inhibitors. Pećin I; Hartgers ML; Hovingh GK; Dent R; Reiner Ž Eur J Prev Cardiol; 2017 Sep; 24(13):1383-1401. PubMed ID: 28644091 [TBL] [Abstract][Full Text] [Related]
11. A boy with autosomal recessive hypercholesterolaemia. Rodenburg J; Wiegman A; Vissers MN; Kastelein JJ; Stalenhoef AF Neth J Med; 2004 Mar; 62(3):89-93. PubMed ID: 15209474 [TBL] [Abstract][Full Text] [Related]
12. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Sahebkar A; Watts GF Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550 [TBL] [Abstract][Full Text] [Related]
13. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene. Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007 [TBL] [Abstract][Full Text] [Related]
14. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment. Raal FJ; Santos RD Atherosclerosis; 2012 Aug; 223(2):262-8. PubMed ID: 22398274 [TBL] [Abstract][Full Text] [Related]
15. Management of familial hypercholesterolaemia in children and adolescents. Justo RN J Paediatr Child Health; 2012 Feb; 48(2):E53-8. PubMed ID: 22017319 [TBL] [Abstract][Full Text] [Related]
16. A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy). Descamps OS; Van Caenegem O; Hermans MP; Balligand JL; Beauloye C; Bondue A; Carlier S; Castermans E; Chenot F; Claeys M; De Block C; de Leener A; De Meester A; Demeure F; De Raedt H; Desmet W; Elegeert I; Guillaume M; Hoffer E; Kacenelenbogen R; Lancellotti P; Langlois M; Leone A; Mertens A; Paquot N; Vanakker O; Vanoverschelde JL; Verhaegen A; Vermeersch P; Wallemacq C; Rietzschel E; Atherosclerosis; 2018 Oct; 277():369-376. PubMed ID: 30270073 [TBL] [Abstract][Full Text] [Related]
18. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824 [TBL] [Abstract][Full Text] [Related]
19. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564 [TBL] [Abstract][Full Text] [Related]
20. Familial Hypercholesterolaemia in the Era of Genetic Testing. Hughes DP; Viljoen A; Wierzbicki AS Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]